Fibrocyte accumulation in the airway walls of COPD patients

The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exac...

Full description

Saved in:
Bibliographic Details
Published inThe European respiratory journal Vol. 54; no. 3; p. 1802173
Main Authors Dupin, Isabelle, Thumerel, Matthieu, Maurat, Elise, Coste, Florence, Eyraud, Edmée, Begueret, Hugues, Trian, Thomas, Montaudon, Michel, Marthan, Roger, Girodet, Pierre-Olivier, Berger, Patrick
Format Journal Article
LanguageEnglish
Published England European Respiratory Society 01.09.2019
Subjects
Online AccessGet full text
ISSN0903-1936
1399-3003
1399-3003
DOI10.1183/13993003.02173-2018

Cover

Loading…
Abstract The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro (“Fibrochir” study). A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45 + FSP1 + cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients. We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival. Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.
AbstractList The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival ("Fibrochir" study).A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45 FSP1 cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.
The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro (“Fibrochir” study). A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45 + FSP1 + cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients. We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival. Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.
The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro (“Fibrochir” study). A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45 + FSP1 + cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients. We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival. Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.
The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro ("Fibrochir" study).A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45+ FSP1+ cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro ("Fibrochir" study).A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45+ FSP1+ cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.
Author Trian, Thomas
Girodet, Pierre-Olivier
Montaudon, Michel
Thumerel, Matthieu
Marthan, Roger
Berger, Patrick
Dupin, Isabelle
Begueret, Hugues
Maurat, Elise
Eyraud, Edmée
Coste, Florence
Author_xml – sequence: 1
  givenname: Isabelle
  orcidid: 0000-0002-4992-9625
  surname: Dupin
  fullname: Dupin, Isabelle
– sequence: 2
  givenname: Matthieu
  orcidid: 0000-0003-4673-8433
  surname: Thumerel
  fullname: Thumerel, Matthieu
– sequence: 3
  givenname: Elise
  surname: Maurat
  fullname: Maurat, Elise
– sequence: 4
  givenname: Florence
  orcidid: 0000-0001-5858-8327
  surname: Coste
  fullname: Coste, Florence
– sequence: 5
  givenname: Edmée
  surname: Eyraud
  fullname: Eyraud, Edmée
– sequence: 6
  givenname: Hugues
  surname: Begueret
  fullname: Begueret, Hugues
– sequence: 7
  givenname: Thomas
  surname: Trian
  fullname: Trian, Thomas
– sequence: 8
  givenname: Michel
  surname: Montaudon
  fullname: Montaudon, Michel
– sequence: 9
  givenname: Roger
  surname: Marthan
  fullname: Marthan, Roger
– sequence: 10
  givenname: Pierre-Olivier
  surname: Girodet
  fullname: Girodet, Pierre-Olivier
– sequence: 11
  givenname: Patrick
  orcidid: 0000-0003-4702-0343
  surname: Berger
  fullname: Berger, Patrick
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31196946$$D View this record in MEDLINE/PubMed
https://hal.science/hal-03457269$$DView record in HAL
BookMark eNp9kUtPwzAQhC1URB_wC5BQjnBIsbOJHYtTVShFqlQOcLY2jqMapUmJE6r-e5K-Dhw4rTT6Zlc7MyS9oiwMIbeMjhmL4ZGBlEApjGnABPgBZfEFGXSq38k9MqCSgs8k8D4ZOvdFKeMhsCvSB8YklyEfkKeZTapS72rjodbNusmxtmXh2cKrV61mqy3uvC3mufPKzJsu35-9TYuYonbX5DLD3Jmb4xyRz9nLx3TuL5avb9PJwtcAsvZRtkeFjjA2QmuZ6RSDKAHJgMdxRCMuRSQwRUE5xSTFNKQ6FSajaMIk4wZG5OGwd4W52lR2jdVOlWjVfLJQnUYhjETA5Q9r2fsDu6nK78a4Wq2t0ybPsTBl41QQxO3jIHjUondHtEnWJj1vPoXTAnAAdFU6V5nsjDCqugrUqQK1r0B1FbQu-celbb0Pta7Q5v96fwH7O4gO
CitedBy_id crossref_primary_10_1007_s00408_024_00720_3
crossref_primary_10_2139_ssrn_3903927
crossref_primary_10_1111_resp_14115
crossref_primary_10_1016_j_jtbi_2023_111448
crossref_primary_10_1164_rccm_202206_1041ST
crossref_primary_10_1080_17460751_2024_2378627
crossref_primary_10_1016_j_intimp_2025_114241
crossref_primary_10_1016_j_rmr_2022_11_015
crossref_primary_10_2147_COPD_S261522
crossref_primary_10_1093_toxres_tfad016
crossref_primary_10_2147_COPD_S436803
crossref_primary_10_3390_bioengineering8110163
crossref_primary_10_1016_j_rmr_2022_01_010
crossref_primary_10_1002_jcsm_13103
crossref_primary_10_3389_fphar_2022_939780
crossref_primary_10_1111_ped_15058
crossref_primary_10_1080_17476348_2024_2380070
crossref_primary_10_1093_ibd_izab157
crossref_primary_10_1183_13993003_01221_2021
crossref_primary_10_7554_eLife_85875_3
crossref_primary_10_1183_16000617_0289_2020
crossref_primary_10_7554_eLife_85875
crossref_primary_10_1186_s12931_023_02509_z
crossref_primary_10_3389_fimmu_2022_852713
crossref_primary_10_1016_j_rmr_2022_03_013
Cites_doi 10.1056/NEJMoa032158
10.1016/S0873-2159(15)30121-5
10.1164/rccm.201410-1874OC
10.1164/rccm.200311-1535OC
10.1165/rcmb.2017-0301PS
10.4049/jimmunol.171.1.380
10.1007/BF03403533
10.1038/ncomms9792
10.1056/NEJMoa1516385
10.1164/rccm.201408-1423OC
10.1097/00001648-199001000-00010
10.1164/rccm.200601-037OC
10.1056/NEJMoa1713901
10.1165/rcmb.2013-0455OC
10.1136/thx.2005.040527
10.1186/1465-9921-7-50
10.1136/thoraxjnl-2015-207696
10.1172/JCI200420997
10.1056/NEJMoa063070
10.1152/physrev.00025.2015
10.1183/09031936.06.00124605
10.1038/nri2990
10.1016/S0140-6736(16)30069-1
10.1186/s12931-018-0798-8
10.1083/jcb.130.2.393
10.1016/j.jaci.2008.10.048
10.1016/j.jaci.2015.08.043
10.1007/978-1-4939-2963-4_3
10.1056/NEJM197410102911503
10.1148/radiol.2422060029
10.1371/journal.pone.0007475
10.1164/rccm.201503-0487OC
10.1111/j.1582-4934.2011.01344.x
10.1111/j.1523-1755.2005.00358.x
10.1056/NEJM196806202782501
10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7
10.1111/resp.12780
10.1016/j.ajpath.2011.08.027
10.1164/rccm.201409-1582OC
10.1016/j.chest.2016.10.031
10.1111/all.13061
10.1073/pnas.1117988108
10.1378/chest.12-1766
ContentType Journal Article
Copyright Copyright ©ERS 2019.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: Copyright ©ERS 2019.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
NPM
7X8
1XC
DOI 10.1183/13993003.02173-2018
DatabaseName CrossRef
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-3003
ExternalDocumentID oai_HAL_hal_03457269v1
31196946
10_1183_13993003_02173_2018
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
18M
1OC
2WC
31~
3O-
53G
5GY
5RE
5VS
8-1
AADJU
AAFWJ
AAYXX
AAZMJ
ABCQX
ABJNI
ABOCM
ABSQV
ACEMG
ACGFO
ACPRK
ACXQS
ADBBV
ADDZX
ADMOG
ADYFA
AENEX
AFFNX
AFHIN
AFZJQ
AIZTS
AJAOE
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CAG
CITATION
COF
CS3
DIK
E3Z
EBS
EJD
F5P
F9R
GX1
H13
INIJC
J5H
KQ8
L7B
LH4
LW6
OK1
P2P
PQQKQ
R0Z
RHI
TER
TR2
W8F
WOQ
X7M
ZE2
ZGI
ZXP
~02
NPM
RHF
7X8
1XC
ID FETCH-LOGICAL-c339t-a94317c5a8e7cc9fcda25b391368850569757ada7060abdad40cd7ef0ae4bf6e3
ISSN 0903-1936
1399-3003
IngestDate Sat Aug 23 06:30:58 EDT 2025
Fri Jul 11 04:40:07 EDT 2025
Wed Feb 19 02:30:21 EST 2025
Tue Jul 01 05:40:07 EDT 2025
Thu Apr 24 23:03:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Copyright ©ERS 2019.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c339t-a94317c5a8e7cc9fcda25b391368850569757ada7060abdad40cd7ef0ae4bf6e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0003-4673-8433
0000-0002-4992-9625
0000-0003-4702-0343
0000-0001-5858-8327
PMID 31196946
PQID 2286943765
PQPubID 23479
ParticipantIDs hal_primary_oai_HAL_hal_03457269v1
proquest_miscellaneous_2286943765
pubmed_primary_31196946
crossref_primary_10_1183_13993003_02173_2018
crossref_citationtrail_10_1183_13993003_02173_2018
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-09-01
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: 2019-09-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The European respiratory journal
PublicationTitleAlternate Eur Respir J
PublicationYear 2019
Publisher European Respiratory Society
Publisher_xml – name: European Respiratory Society
References 2024102101003485000_54.3.1802173.34
2024102101003485000_54.3.1802173.33
2024102101003485000_54.3.1802173.14
2024102101003485000_54.3.1802173.36
Jenkins (2024102101003485000_54.3.1802173.42) 2017; 151
2024102101003485000_54.3.1802173.35
2024102101003485000_54.3.1802173.16
2024102101003485000_54.3.1802173.37
2024102101003485000_54.3.1802173.18
2024102101003485000_54.3.1802173.17
2024102101003485000_54.3.1802173.39
Xue (2024102101003485000_54.3.1802173.45) 2003; 63
2024102101003485000_54.3.1802173.30
2024102101003485000_54.3.1802173.10
2024102101003485000_54.3.1802173.32
2024102101003485000_54.3.1802173.19
Dupin (2024102101003485000_54.3.1802173.38) 2018; 58
Mitsuhashi (2024102101003485000_54.3.1802173.15) 2015; 6
2024102101003485000_54.3.1802173.1
2024102101003485000_54.3.1802173.23
Vestbo (2024102101003485000_54.3.1802173.7) 2016; 387
2024102101003485000_54.3.1802173.22
2024102101003485000_54.3.1802173.44
2024102101003485000_54.3.1802173.25
2024102101003485000_54.3.1802173.2
2024102101003485000_54.3.1802173.24
2024102101003485000_54.3.1802173.5
2024102101003485000_54.3.1802173.27
2024102101003485000_54.3.1802173.4
2024102101003485000_54.3.1802173.26
2024102101003485000_54.3.1802173.29
2024102101003485000_54.3.1802173.6
2024102101003485000_54.3.1802173.28
Dupin (2024102101003485000_54.3.1802173.12) 2016; 137
Bucala (2024102101003485000_54.3.1802173.11) 1994; 1
Hu (2024102101003485000_54.3.1802173.31) 2015; 1343
2024102101003485000_54.3.1802173.40
Heukels (2024102101003485000_54.3.1802173.41) 2018; 19
2024102101003485000_54.3.1802173.21
2024102101003485000_54.3.1802173.43
2024102101003485000_54.3.1802173.20
Wright (2024102101003485000_54.3.1802173.13) 2017; 72
2024102101003485000_54.3.1802173.9
2024102101003485000_54.3.1802173.8
Ko (2024102101003485000_54.3.1802173.3) 2016; 21
References_xml – ident: 2024102101003485000_54.3.1802173.1
  doi: 10.1056/NEJMoa032158
– ident: 2024102101003485000_54.3.1802173.6
  doi: 10.1016/S0873-2159(15)30121-5
– ident: 2024102101003485000_54.3.1802173.21
  doi: 10.1164/rccm.201410-1874OC
– ident: 2024102101003485000_54.3.1802173.27
  doi: 10.1164/rccm.200311-1535OC
– volume: 58
  start-page: 288
  year: 2018
  ident: 2024102101003485000_54.3.1802173.38
  article-title: Fibrocytes in asthma and chronic obstructive pulmonary disease: variations on the same theme
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2017-0301PS
– ident: 2024102101003485000_54.3.1802173.14
  doi: 10.4049/jimmunol.171.1.380
– volume: 1
  start-page: 71
  year: 1994
  ident: 2024102101003485000_54.3.1802173.11
  article-title: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair
  publication-title: Mol Med
  doi: 10.1007/BF03403533
– volume: 6
  start-page: 8792
  year: 2015
  ident: 2024102101003485000_54.3.1802173.15
  article-title: Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
  publication-title: Nat Commun
  doi: 10.1038/ncomms9792
– ident: 2024102101003485000_54.3.1802173.8
  doi: 10.1056/NEJMoa1516385
– ident: 2024102101003485000_54.3.1802173.20
  doi: 10.1164/rccm.201408-1423OC
– ident: 2024102101003485000_54.3.1802173.24
  doi: 10.1097/00001648-199001000-00010
– ident: 2024102101003485000_54.3.1802173.35
  doi: 10.1164/rccm.200601-037OC
– ident: 2024102101003485000_54.3.1802173.9
  doi: 10.1056/NEJMoa1713901
– ident: 2024102101003485000_54.3.1802173.18
  doi: 10.1165/rcmb.2013-0455OC
– ident: 2024102101003485000_54.3.1802173.4
  doi: 10.1136/thx.2005.040527
– ident: 2024102101003485000_54.3.1802173.39
  doi: 10.1186/1465-9921-7-50
– ident: 2024102101003485000_54.3.1802173.19
  doi: 10.1136/thoraxjnl-2015-207696
– ident: 2024102101003485000_54.3.1802173.30
  doi: 10.1172/JCI200420997
– ident: 2024102101003485000_54.3.1802173.5
  doi: 10.1056/NEJMoa063070
– ident: 2024102101003485000_54.3.1802173.37
  doi: 10.1152/physrev.00025.2015
– ident: 2024102101003485000_54.3.1802173.25
  doi: 10.1183/09031936.06.00124605
– ident: 2024102101003485000_54.3.1802173.26
  doi: 10.1038/nri2990
– volume: 387
  start-page: 1817
  year: 2016
  ident: 2024102101003485000_54.3.1802173.7
  article-title: Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30069-1
– volume: 19
  start-page: 90
  year: 2018
  ident: 2024102101003485000_54.3.1802173.41
  article-title: Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis
  publication-title: Respir Res
  doi: 10.1186/s12931-018-0798-8
– ident: 2024102101003485000_54.3.1802173.28
  doi: 10.1083/jcb.130.2.393
– ident: 2024102101003485000_54.3.1802173.40
  doi: 10.1016/j.jaci.2008.10.048
– volume: 137
  start-page: 1036
  year: 2016
  ident: 2024102101003485000_54.3.1802173.12
  article-title: Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.08.043
– volume: 1343
  start-page: 19
  year: 2015
  ident: 2024102101003485000_54.3.1802173.31
  article-title: Flow cytometric identification of fibrocytes in the human circulation
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-2963-4_3
– ident: 2024102101003485000_54.3.1802173.10
  doi: 10.1056/NEJM197410102911503
– ident: 2024102101003485000_54.3.1802173.22
  doi: 10.1148/radiol.2422060029
– ident: 2024102101003485000_54.3.1802173.32
  doi: 10.1371/journal.pone.0007475
– ident: 2024102101003485000_54.3.1802173.43
  doi: 10.1164/rccm.201503-0487OC
– ident: 2024102101003485000_54.3.1802173.33
  doi: 10.1111/j.1582-4934.2011.01344.x
– ident: 2024102101003485000_54.3.1802173.2
– ident: 2024102101003485000_54.3.1802173.29
  doi: 10.1111/j.1523-1755.2005.00358.x
– ident: 2024102101003485000_54.3.1802173.34
  doi: 10.1056/NEJM196806202782501
– ident: 2024102101003485000_54.3.1802173.44
  doi: 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7
– volume: 21
  start-page: 1152
  year: 2016
  ident: 2024102101003485000_54.3.1802173.3
  article-title: Acute exacerbation of COPD
  publication-title: Respirology
  doi: 10.1111/resp.12780
– ident: 2024102101003485000_54.3.1802173.16
  doi: 10.1016/j.ajpath.2011.08.027
– ident: 2024102101003485000_54.3.1802173.23
  doi: 10.1164/rccm.201409-1582OC
– volume: 151
  start-page: 686
  year: 2017
  ident: 2024102101003485000_54.3.1802173.42
  article-title: Improving the management of COPD in women
  publication-title: Chest
  doi: 10.1016/j.chest.2016.10.031
– volume: 72
  start-page: 645
  year: 2017
  ident: 2024102101003485000_54.3.1802173.13
  article-title: Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease
  publication-title: Allergy
  doi: 10.1111/all.13061
– ident: 2024102101003485000_54.3.1802173.17
  doi: 10.1073/pnas.1117988108
– ident: 2024102101003485000_54.3.1802173.36
  doi: 10.1378/chest.12-1766
– volume: 63
  start-page: 3386
  year: 2003
  ident: 2024102101003485000_54.3.1802173.45
  article-title: The gatekeeper effect of epithelial–mesenchymal transition regulates the frequency of breast cancer metastasis
  publication-title: Cancer Res
SSID ssj0016431
Score 2.4217703
Snippet The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that...
SourceID hal
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1802173
SubjectTerms Life Sciences
Title Fibrocyte accumulation in the airway walls of COPD patients
URI https://www.ncbi.nlm.nih.gov/pubmed/31196946
https://www.proquest.com/docview/2286943765
https://hal.science/hal-03457269
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZNCqWX0ne3L9zSW-vUtiw_6ClssmzaTdLDLuxNSLJMFrZ22LUb0l_fGVl-BLYl7cUYYcn2zMcwo9F8Q8iHiGW5CETgpgmmGSXNXPDyfTcIGUs8mfvSZExPz6LpIvy6ZMu-raKpLqnkgfq1s67kf7QKY6BXrJL9B812i8IA3IN-4QoahuutdDyBWLdU1xVSYqj6h-3E1R5dFKvNlbj-eCXWDUPy-Pz7Ucujuh06pQiVbld-M8i9Dz_COLuXDePAyVZgvqLDxPwCqzibfL9pIL7Sdb_VXcNq9gRZnwkaY3GJ8ZzXpSk4HG4_-P35qtZigofjUs9rrJTeMWbNbMMVbeFEd1vvBFkkcDZOPsBwiYLCrYG-wZV9ds4ni9mMz4-X8z1yN4AgAftXHJ1863JI4Gs14bb9GMs5BS_5vOMVN_ySvQs8FfunkMO4HvOH5IGNGZzDBgCPyB1dPCb3Tu2piCfkS4cDZ4gDZ1U4gAOnwYFjcOCUuYM4cFocPCWLyfF8PHVtUwxXUZpWrkjR5VNMJDpWKs1VJgImaerTKEnQnU1jFotMICuSkJnIQk9lsc49oUOZR5o-I_tFWegXxEHmo1RSnbFQhLEUiYxEwhLly8yPZRCNSNCKhCvLGI-NS9bcRI4J5a0cuZEjRzmOyKdu0mVDmPL3x9-DrLsnkex8ejjjOObRkMVBlP70R-RdqwoO1g9TWqLQZb3l8AsRCCSO2Ig8b3TUrUV9pH4Ko5e3mP2K3O_B_ZrsV5tavwFvs5JvDah-AygveVs
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fibrocyte+accumulation+in+the+airway+walls+of+COPD+patients&rft.jtitle=The+European+respiratory+journal&rft.au=Dupin%2C+Isabelle&rft.au=Thumerel%2C+Matthieu&rft.au=Maurat%2C+Elise&rft.au=Coste%2C+Florence&rft.date=2019-09-01&rft.issn=1399-3003&rft.eissn=1399-3003&rft.volume=54&rft.issue=3&rft_id=info:doi/10.1183%2F13993003.02173-2018&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon